Minimally invasive video-assisted thyroidectomy (MIVAT) and thyroid cancer: a single centre 10-year follow-up

Thyroid cancer is the most frequent endocrine malignancy, has low recurrence rates and it is particularly common among young women. Minimally invasive video-assisted thyroidectomy (MIVAT), introduced about 25 years ago, is still the most widespread minimally endoscopic procedure. The aim of the study was to obtain long-term follow-up of oncological outcomes and postoperative complications after MIVAT, performed for differentiated thyroid carcinoma.